ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN POSTKIDNEY TRANSPLANT CMV AT RISK RECIPIENTS - A CONTROLLED, COMPARATIVE-STUDY OF 2 REGIMENS (750 MG BID AND 500 MG BID)

Authors
AHSAN N HOLMAN MJ SONDERBYE L LANGHOFF E YANG HC
Citation
N. Ahsan et al., ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN POSTKIDNEY TRANSPLANT CMV AT RISK RECIPIENTS - A CONTROLLED, COMPARATIVE-STUDY OF 2 REGIMENS (750 MG BID AND 500 MG BID), Transplantation proceedings, 30(4), 1998, pp. 1383-1385
Citations number
16
Categorie Soggetti
Transplantation,Surgery,Immunology
Journal title
Transplantation proceedings → ACNP
ISSN journal
00411345
Volume
30
Issue
4
Year of publication
1998
Pages
1383 - 1385
Database
ISI
SICI code
0041-1345(1998)30:4<1383:OGITPO>2.0.ZU;2-M